Abstract:Knowledge regarding the genomic structure of Enterobacter spp., the second most prevalent carbapenemase-producing Enterobacteriaceae, remains limited. Here we sequenced 97 clinical Enterobacter species isolates that were both carbapenem susceptible and resistant from various geographic regions to decipher the molecular origins of carbapenem resistance and to understand the changing phylogeny of these emerging and drug-resistant pathogens. Of the carbapenem-resistant isolates, 30 possessed blaKPC-2, 40 had blaKPC-3, 2 had blaKPC-4, and 2 had blaNDM-1. Twenty-three isolates were carbapenem susceptible. Six genomes were sequenced to completion, and their sizes ranged from 4.6 to 5.1 Mbp. Phylogenomic analysis placed 96 of these genomes, 351 additional Enterobacter genomes downloaded from NCBI GenBank, and six newly sequenced type strains into 19 phylogenomic groups—18 groups (A to R) in the Enterobacter cloacae complex and Enterobacter aerogenes. Diverse mechanisms underlying the molecular evolutionary trajectory of these drug-resistant Enterobacter spp. were revealed, including the acquisition of an antibiotic resistance plasmid, followed by clonal spread, horizontal transfer of blaKPC-harboring plasmids between different phylogenomic groups, and repeated transposition of the blaKPC gene among different plasmid backbones. Group A, which comprises multilocus sequence type 171 (ST171), was the most commonly identified (23% of isolates). Genomic analysis showed that ST171 isolates evolved from a common ancestor and formed two different major clusters; each acquiring unique blaKPC-harboring plasmids, followed by clonal expansion. The data presented here represent the first comprehensive study of phylogenomic interrogation and the relationship between antibiotic resistance and plasmid discrimination among carbapenem-resistant Enterobacter spp., demonstrating the genetic diversity and complexity of the molecular mechanisms driving antibiotic resistance in this genus.IMPORTANCE Enterobacter spp., especially carbapenemase-producing Enterobacter spp., have emerged as a clinically significant cause of nosocomial infections. However, only limited information is available on the distribution of carbapenem resistance across this genus. Augmenting this problem is an erroneous identification of Enterobacter strains because of ambiguous typing methods and imprecise taxonomy. In this study, we used a whole-genome-based comparative phylogenetic approach to (i) revisit and redefine the genus Enterobacter and (ii) unravel the emergence and evolution of the Klebsiella pneumoniae carbapenemase-harboring Enterobacter spp. Using genomic analysis of 447 sequenced strains, we developed an improved understanding of the species designations within this complex genus and identified the diverse mechanisms driving the molecular evolution of carbapenem resistance. The findings in this study provide a solid genomic framework that will serve as an important resource in the future development of molecular diagnostics and in supporting drug discovery programs.

Reexamining the Association of AmpC Variants with Enterobacter Species in the Context of Updated Taxonomy

Emergence of novel variants of DNA gyrase subunit A gyrA gene in drug-resistant Enterobacter aerogenes

Molecular Epidemiology and Genomic Characterization of a Plasmid-Mediated Mcr-10 and Blandm-1 Co-Harboring Multidrug-Resistant Enterobacter Asburiae.

Precise Species Identification for Enterobacter: a Genome Sequence-Based Study with Reporting of Two Novel Species, Enterobacter <i>quasiroggenkampii</i> sp. nov. and <i>Enterobacter</i> <i>quasimori</i> sp. nov.

β-Lactamase-encoding Genes of Multiple-drug-resistant Enterobacter cloacae

The Status of Drug Resistance and Ampc Gene Expression in Enterobacter Cloacae

Drug-resistance Mechanisms and Prevalence of Enterobacter Cloacae Resistant to Multi-Antibiotics

Genomic Analysis of Enterobacter Species Isolated from Patients in United States Hospitals

Complete Nucleotide Sequences of Bla(ctx-M)-harboring IncF Plasmids from Community-Associated Escherichia Coli Strains in the United States.

Detection of Plasmid-Mediated β-Lactamase Genes and Emergence of a Novel AmpC (CMH-1) in Enterobacter cloacae at a Medical Center in Southern Taiwan

Characterization of the Population Structure, Drug Resistance Mechanisms and Plasmids of the Community-Associated Enterobacter Cloacae Complex in China

Distribution of the ACME-arcA Gene among Meticillin-Resistant Staphylococcus Haemolyticus and Identification of a Novel Ccr Allotype in ACME-arcA-positive Isolates.

Complete Genomic Characterization of Two Escherichia Coli Lineages Responsible for a Cluster of Carbapenem-Resistant Infections in a Chinese Hospital

Emergence of Carbapenem-Resistant Enterobacter Cloacae Carrying IMP-26 Metallo-Β-lactamase in Class 1 Integron and TEM-104 Extended-Spectrum Β- Lactamase in Conjugative Plasmid

Carbapenem and Colistin Resistance in Enterobacter: Determinants and Clones.

Whole-Genome Sequencing-Based Species Classification, Multilocus Sequence Typing, and Antimicrobial Resistance Mechanism Analysis of the Enterobacter cloacae Complex in Southern China

Species Classification and Novel Plasmid Identifications in Arcobacter cryaerophilus and Arcobacter cryaerophilus-like Organisms

Antimicrobial Resistance and Genomic Characterization of Escherichia Coli from Pigs and Chickens in Zhejiang, China

Genomic Insights into the ESBL and MCR-1-producing ST648 Escherichiacoli with Multi-Drug Resistance.

Comprehensive Genome Analysis of Carbapenemase-Producing Enterobacter Spp.: New Insights into Phylogeny, Population Structure, and Resistance Mechanisms.

Revisiting the taxonomy of and related species